Do high levels of folic acid in women’s blood impact the outcome of IVF?

Of significant scientific and practical interest is the relationship between the blood plasma levels of folic acid at preconception and the outcome of pregnancy. A phase III clinical trial on the efficacy and safety of the biosimilar follitropin alfa has recently been completed within the ongoing as...

Full description

Bibliographic Details
Main Authors: M. A. Polzikov, D. V. Blinov, T. I. Ushakova, Z. B. Barakoeva, L. A. Vovk, M. M. Ovchinnikova, Ju. A. Fetisova, E. V. Nikolaeva, A. A. Nikolaev, O. V. Sergeyev
Format: Article
Language:Russian
Published: IRBIS LLC 2020-01-01
Series:Акушерство, гинекология и репродукция
Subjects:
Online Access:https://www.gynecology.su/jour/article/view/600
_version_ 1797884080200613888
author M. A. Polzikov
D. V. Blinov
T. I. Ushakova
Z. B. Barakoeva
L. A. Vovk
M. M. Ovchinnikova
Ju. A. Fetisova
E. V. Nikolaeva
A. A. Nikolaev
O. V. Sergeyev
author_facet M. A. Polzikov
D. V. Blinov
T. I. Ushakova
Z. B. Barakoeva
L. A. Vovk
M. M. Ovchinnikova
Ju. A. Fetisova
E. V. Nikolaeva
A. A. Nikolaev
O. V. Sergeyev
author_sort M. A. Polzikov
collection DOAJ
description Of significant scientific and practical interest is the relationship between the blood plasma levels of folic acid at preconception and the outcome of pregnancy. A phase III clinical trial on the efficacy and safety of the biosimilar follitropin alfa has recently been completed within the ongoing assisted reproductive technology (ART) programs. The results confirmed the therapeutic equivalence of the investigational agent to the reference drug. In this trial, women with tubal infertility or male factor infertility were included. The study did not include women with endometriosis and polycystic ovary syndrome. A total of 118 patients were recruited; of those, 110 were randomized; then the 110 women underwent hormonal stimulation and 98 of them underwent embryo transfer. Blood samples were taken within a period not exceeding 28 days before the start of the stimulation; the samples were analyzed for folic acid (FA), trace elements and hormones. The results were grouped by quartiles (Q) according to the levels of FA in the blood serum: Q1 – 2.9–10.7 ng/ml, Q2 – 10.8–20.5 ng/ml, Q3 – 20.6–32.9 ng/ml, and Q4 ≥ 33.0 ng/ml. In addition, group distribution was also made according to the WHO recommendations: possible FA deficiency – 3.0–5.9 ng/ml, normal – 6.0–20.0 ng/ml, and elevated levels – more than 20 ng/ml. A significant decrease in the number of fertilized oocytes, clinical pregnancies and live births in Q4 (increased FA) compared with Q1 was found. Also, in women with high levels of FA, the number of aspirated oocytes was significantly lower than that in women with normal or decreased FA levels. We also found a significant inverse relationship between the number of aspirated oocytes and the levels of estradiol and serum FA. Plasma FA levels > 20 ng/ml detected prior to the IVF procedure may be associated with a low number of aspirated oocytes, and FA levels > 33 ng/ml – with a reduced number of fertilized oocytes, clinical pregnancies and live births. Thus, the excessive content of FA in the body can contribute to a worse outcome of IVF programs.
first_indexed 2024-04-10T04:01:54Z
format Article
id doaj.art-ac519fcad99148a5acc35f172cc1bd3c
institution Directory Open Access Journal
issn 2313-7347
2500-3194
language Russian
last_indexed 2024-04-10T04:01:54Z
publishDate 2020-01-01
publisher IRBIS LLC
record_format Article
series Акушерство, гинекология и репродукция
spelling doaj.art-ac519fcad99148a5acc35f172cc1bd3c2023-03-13T07:09:50ZrusIRBIS LLCАкушерство, гинекология и репродукция2313-73472500-31942020-01-0113431332510.17749/2313-7347.2019.13.4.313-325523Do high levels of folic acid in women’s blood impact the outcome of IVF?M. A. Polzikov0D. V. Blinov1T. I. Ushakova2Z. B. Barakoeva3L. A. Vovk4M. M. Ovchinnikova5Ju. A. Fetisova6E. V. Nikolaeva7A. A. Nikolaev8O. V. Sergeyev9IVFarma LLCInstitute for Preventive and Social Medicine; Moscow Haass Medical – Social Institute; Lapino Clinical Hospital, GC «Mother and Child»IVFarma LLC; Institute for Preventive and Social Medicine«AltraVita» Human Reproduction ClinicPerinatal Medical Center, GC «Mother and Child»Lapino Clinical Hospital, GC «Mother and Child»Perinatal Medical Center, GC «Mother and Child»Perinatal Medical Center, GC «Mother and Child»Lapino Clinical Hospital, GC «Mother and Child»A.N. Belozersky Research Institute of Physico-Chemical Biology, Lomonosov Moscow State UniversityOf significant scientific and practical interest is the relationship between the blood plasma levels of folic acid at preconception and the outcome of pregnancy. A phase III clinical trial on the efficacy and safety of the biosimilar follitropin alfa has recently been completed within the ongoing assisted reproductive technology (ART) programs. The results confirmed the therapeutic equivalence of the investigational agent to the reference drug. In this trial, women with tubal infertility or male factor infertility were included. The study did not include women with endometriosis and polycystic ovary syndrome. A total of 118 patients were recruited; of those, 110 were randomized; then the 110 women underwent hormonal stimulation and 98 of them underwent embryo transfer. Blood samples were taken within a period not exceeding 28 days before the start of the stimulation; the samples were analyzed for folic acid (FA), trace elements and hormones. The results were grouped by quartiles (Q) according to the levels of FA in the blood serum: Q1 – 2.9–10.7 ng/ml, Q2 – 10.8–20.5 ng/ml, Q3 – 20.6–32.9 ng/ml, and Q4 ≥ 33.0 ng/ml. In addition, group distribution was also made according to the WHO recommendations: possible FA deficiency – 3.0–5.9 ng/ml, normal – 6.0–20.0 ng/ml, and elevated levels – more than 20 ng/ml. A significant decrease in the number of fertilized oocytes, clinical pregnancies and live births in Q4 (increased FA) compared with Q1 was found. Also, in women with high levels of FA, the number of aspirated oocytes was significantly lower than that in women with normal or decreased FA levels. We also found a significant inverse relationship between the number of aspirated oocytes and the levels of estradiol and serum FA. Plasma FA levels > 20 ng/ml detected prior to the IVF procedure may be associated with a low number of aspirated oocytes, and FA levels > 33 ng/ml – with a reduced number of fertilized oocytes, clinical pregnancies and live births. Thus, the excessive content of FA in the body can contribute to a worse outcome of IVF programs.https://www.gynecology.su/jour/article/view/600folic acidfolatespreconceptionpregnancyin vitro fertilizationivfassisted reproductive therapyartoutcomesaspirated oocytesfertilized oocytesbiochemical pregnancyclinical pregnancylive birth
spellingShingle M. A. Polzikov
D. V. Blinov
T. I. Ushakova
Z. B. Barakoeva
L. A. Vovk
M. M. Ovchinnikova
Ju. A. Fetisova
E. V. Nikolaeva
A. A. Nikolaev
O. V. Sergeyev
Do high levels of folic acid in women’s blood impact the outcome of IVF?
Акушерство, гинекология и репродукция
folic acid
folates
preconception
pregnancy
in vitro fertilization
ivf
assisted reproductive therapy
art
outcomes
aspirated oocytes
fertilized oocytes
biochemical pregnancy
clinical pregnancy
live birth
title Do high levels of folic acid in women’s blood impact the outcome of IVF?
title_full Do high levels of folic acid in women’s blood impact the outcome of IVF?
title_fullStr Do high levels of folic acid in women’s blood impact the outcome of IVF?
title_full_unstemmed Do high levels of folic acid in women’s blood impact the outcome of IVF?
title_short Do high levels of folic acid in women’s blood impact the outcome of IVF?
title_sort do high levels of folic acid in women s blood impact the outcome of ivf
topic folic acid
folates
preconception
pregnancy
in vitro fertilization
ivf
assisted reproductive therapy
art
outcomes
aspirated oocytes
fertilized oocytes
biochemical pregnancy
clinical pregnancy
live birth
url https://www.gynecology.su/jour/article/view/600
work_keys_str_mv AT mapolzikov dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT dvblinov dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT tiushakova dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT zbbarakoeva dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT lavovk dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT mmovchinnikova dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT juafetisova dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT evnikolaeva dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT aanikolaev dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf
AT ovsergeyev dohighlevelsoffolicacidinwomensbloodimpacttheoutcomeofivf